Back

prof. dr. P.O. Witteveen

prof. dr. P.O. Witteveen

Full Professor
prof. dr. P.O. Witteveen
  • Department of Medical Oncology

Research Programs

Strategic Program Cancer

Side Activities

2021 Editorial Board Member European Journal of Gynaecological Oncology

2018 Chair Central Incident Committee (MIP commissie)

2018 Dutch working group on Evidence Based Guidelines in Ovarian Cancer

2018 Dutch working group on Evidence Based Guidelines in Endometrial Cancer

2018 Dutch working group on Evidence Based Guidelines in Cervical Cancer

2015 Advisory board Priority Program Cancer, University Medical Center Utrecht, Cancer Center

2015 Steering Committee Expensive Medicines, University Medical Center Utrecht, Cancer Center

2014 Member Dutch Advisory group Cancer in pregnancy (AKZ)

2013 Dutch working Group on Evidence Based guidelines on fertility preservation in Cancer Treatment

2013 Member of working group NFU oncology on behalf of University Medical Center Utrecht, Cancer Center

2005 Working group on gynaecological cancers of the comprehensive cancer center Utrecht (TWGO)

Research Output (135)

Distinct Genomic Profiles Are Associated with Treatment Response and Survival in Ovarian Cancer

de Witte Chris J, Kutzera Joachim, van Hoeck Arne, Nguyen Luan, Boere Ingrid A, Jalving Mathilde, Ottevanger Petronella B, van Schaik-van de Mheen Christa, Stevense Marion, Kloosterman Wigard P, Zweemer Ronald P, Cuppen Edwin, Witteveen Petronella O 2 Mar 2022, In: Cancers. 14 , p. 1-18

Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)

Post C C B, Westermann A M, Boere I A, Witteveen P O, Ottevanger P B, Sonke G S, Lalisang R I, Putter H, Meershoek-Klein Kranenbarg E, Braak J P B M, Creutzberg C L, Bosse T, Kroep J R 2022, In: Gynecologic Oncology. 165 , p. 223-229 7 p.

Functional decline after surgery in older patients with head and neck cancer

Bruijnen Cheryl P., de Groot Lotte G.R., Vondeling Ariel M., de Bree Remco, van den Bos Frederiek, Witteveen Petronella O., Emmelot- Vonk Mariëlle H. 30 Oct 2021, In: Oral Oncology. 123

IMPACT OF HORMONAL BIOMARKERS ON RESPONSE TO HORMONAL THERAPY IN ADVANCED AND RECURRENT ENDOMETRIAL CANCER

VAN Weelden Willem Jan, Lalisang Roy I, Bulten Johan, Lindemann Kristina, VAN Beekhuizen Heleen J, Trum Hans, Boll Dorry, Werner Henrica M J, VAN Lonkhuijzen Luc R C W, Yigit Refika, Forsse David, Witteveen Petronella O, Galaal Khadra, VAN Ginkel Alexandra, Bignotti Eliana, Weinberger Vit, Sweegers Sanne, Kroep Judith R, Cabrera Silvia, Snijders Marc P L M, Inda Márcia A, Eriksson Ane Gerda Z, Krakstad Camilla, Romano Andrea, VAN DE Stolpe Anja, Pijnenborg Johanna M A 18 May 2021, In: American Journal of Obstetrics and Gynecology. 225 , p. 407.e1-407.e16

The attributive value of comprehensive surgical staging in clinically early-stage epithelial ovarian carcinoma:A systematic review and meta-analysis

van de Vorst Renée E W M, Hoogendam Jacob P, van der Aa Maaike A, Witteveen Petronella O, Zweemer Ronald P, Gerestein Cornelis G 10 Apr 2021, In: Gynecologic Oncology. 161 , p. 876-883 8 p.

[18F]FDG and [18F]FES positron emission tomography for disease monitoring and assessment of anti-hormonal treatment eligibility in granulosa cell tumors of the ovary

Roze Joline F, van Meurs Hannah S, Monroe Glen R, Veldhuis Wouter B, van Lonkhuijzen Luc R C W, Bennink Roel J, Groeneweg Jolijn W, Witteveen Petronella O, Jonges Geertruida N, Zweemer Ronald P, Braat Arthur J A T 30 Mar 2021, In: Oncotarget. 12 , p. 665-673 9 p.

Development and testing of a tailored online fertility preservation decision aid for female cancer patients

van den Berg Michelle, van der Meij Elleke, Bos Annelies M E, Boshuizen Marieke C S, Determann Domino, van Eekeren Ramon R J P, Lok Christianne A R, Schaake Eva E, Witteveen Petronella O, Wondergem Marielle J, Braat Didi D M, Beerendonk Catharina C M, Hermens Rosella P M G Mar 2021, In: Cancer Medicine. 10 , p. 1576-1588 13 p.

In Vitro Systematic Drug Testing Reveals Carboplatin, Paclitaxel, and Alpelisib as a Potential Novel Combination Treatment for Adult Granulosa Cell Tumors

Roze Joline, Sendino Garví Elena, Stelloo Ellen, Stangl Christina, Sereno Ferdinando, Duran Karen, Groeneweg Jolijn, Paijens Sterre, Nijman Hans, van Meurs Hannah, van Lonkhuijzen Luc, Piek Jurgen, Lok Christianne, Jonges Geertruida, Witteveen Petronella, Verheijen René, van Haaften Gijs, Zweemer Ronald, Monroe Glen 1 Feb 2021, In: Cancers. 13 , p. 1-18 18 p.

Population Pharmacokinetics of Docetaxel, Paclitaxel, Doxorubicin and Epirubicin in Pregnant Women with Cancer:A Study from the International Network of Cancer, Infertility and Pregnancy (INCIP)

Janssen Julie M, Van Calsteren Kristel, Dorlo Thomas P C, Halaska Michael J, Fruscio Robert, Ottevanger Petronella, Schröder Carolien P, Boere Ingrid, Witteveen Petronella O, Painter Rebecca C, Bekkers Ruud, Drochytek Vit, Beijnen Jos H, Huitema Alwin D R, Amant Frederic C H 28 Jan 2021, In: Clinical Pharmacokinetics. 60 , p. 775-784 10 p.

Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva:An efficacy study

van Triest Baukelien, Rasing Marnix, van der Velden Jacobus, de Hullu Joanne, Witteveen Petronella O., Beukema Jannet C., van der Steen-Banasik Elsbieta, Westerveld Henrike, Snyers An, Peters Max, Creutzberg Carien L., Nout Remi A., Lutgens Ludy, Jürgenliemk-Schulz Ina 2021, In: Gynecologic Oncology. 163 , p. 117-124 8 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet